This grant is for advancing single-molecule protein sequencing through technology development. The National Institutes of Health (NIH) solicits applications for this R43/R44 Funding Opportunity Announcement, aiming to catalyze major breakthroughs in the field. The core objective is to enable the routine generation of protein sequencing data, ensuring it meets high standards of scale, speed, cost-effectiveness, and accuracy. Over the next five years, successful proposals will contribute to developing technologies that can be broadly applied in studies of genome biology and function, as well as integrated into general biomedical and clinical research. This initiative seeks innovative solutions to overcome current limitations in protein sequencing.
Opportunity ID: 334700
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-247 |
| Funding Opportunity Title: | Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.172 — Human Genome Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 13, 2021 |
| Last Updated Date: | Jul 13, 2021 |
| Original Closing Date for Applications: | Jun 15, 2023 |
| Current Closing Date for Applications: | Jun 15, 2023 |
| Archive Date: | Jul 21, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications to catalyze major advances in single-molecule protein sequencing through technology development. The goal of this initiative is to achieve technological advances over the next five years that enable generation of protein sequencing data at sufficient scale, speed, cost and accuracy to use routinely in studies of genome biology and function, and in biomedical and clinical research in general. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-247.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 334700 Full Announcement-PAR-21-247 -> PAR-21-247-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270950 | Dec 16, 2021 | Jan 24, 2023 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268178 | Sep 30, 2021 | Jan 24, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278354 | Nov 14, 2022 | Jun 15, 2023 | View |
Package 1
Mandatory forms
334700 RR_SF424_5_0-5.0.pdf
334700 PHS398_CoverPageSupplement_5_0-5.0.pdf
334700 RR_OtherProjectInfo_1_4-1.4.pdf
334700 PerformanceSite_4_0-4.0.pdf
334700 RR_KeyPersonExpanded_4_0-4.0.pdf
334700 RR_Budget_3_0-3.0.pdf
334700 PHS398_ResearchPlan_4_0-4.0.pdf
334700 SBIR_STTR_Information_3_0-3.0.pdf
334700 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334700 RR_SubawardBudget30_3_0-3.0.pdf
334700 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334700 RR_SF424_2_0-2.0.pdf
334700 PHS398_CoverPageSupplement_5_0-5.0.pdf
334700 RR_OtherProjectInfo_1_4-1.4.pdf
334700 PerformanceSite_2_0-2.0.pdf
334700 RR_KeyPersonExpanded_2_0-2.0.pdf
334700 RR_Budget_1_4-1.4.pdf
334700 PHS398_ResearchPlan_4_0-4.0.pdf
334700 SBIR_STTR_Information_1_3-1.3.pdf
334700 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334700 RR_SubawardBudget30_1_4-1.4.pdf
334700 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
334700 RR_SF424_5_0-5.0.pdf
334700 PHS398_CoverPageSupplement_5_0-5.0.pdf
334700 RR_OtherProjectInfo_1_4-1.4.pdf
334700 PerformanceSite_4_0-4.0.pdf
334700 RR_KeyPersonExpanded_4_0-4.0.pdf
334700 RR_Budget_3_0-3.0.pdf
334700 PHS398_ResearchPlan_5_0-5.0.pdf
334700 SBIR_STTR_Information_3_0-3.0.pdf
334700 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334700 RR_SubawardBudget30_3_0-3.0.pdf
334700 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
